{"id":"https://genegraph.clinicalgenome.org/r/7d5bc0a0-5cb3-4106-9f85-73a0e049057fv1.0","type":"EvidenceStrengthAssertion","dc:description":"*TLL1* was first reported in relation to autosomal dominant congenital heart disease in 2009 (Stanczak et al. 2009, PMID: 18830233). Four variants (missense, frameshift) that have been reported in 4 probands in 3 publications (PMID: 18830233, 30293987, 31570783) are included in this curation. There are more variants reported in individuals with CHD in 6 publications, all of which were not scored due to a high minor allele frequency (>0.00001) in gnomAD v.4, being located in the 5â€™ untranslated region of the gene, the proband having a syndromic phenotype, and/or the proband having an unclear phenotype (PMID: 18830233, 27418595, 28358424, 30293987, 32552793, 34328347). The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by expression data in mouse embryos (PMID: 10331975), protein interaction data (PMID: 19366374, 26744331), and a mouse model showing heart defects (PMID: 10331975). In summary, there is limited evidence supporting the relationship between *TLL1* and autosomal dominant congenital heart disease. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date May 13th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/7d5bc0a0-5cb3-4106-9f85-73a0e049057f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-06-27T16:03:43.962Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-05-13T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cffd741a-0741-41aa-ad2b-af6db164aa34","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cffd741a-0741-41aa-ad2b-af6db164aa34_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31570783","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1c73e28-70a9-48c4-8040-5acffce9def0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012464.5(TLL1):c.1379-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358684644"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8e386433-3c13-423c-8f1e-f952b0325835","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e386433-3c13-423c-8f1e-f952b0325835_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data in Sieron et al. 2019 (PMID: 30538173) but experts chose not to score due to the same functional study providing evidence for a functional effect in a common variant","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8e386433-3c13-423c-8f1e-f952b0325835_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18830233","allele":{"id":"https://genegraph.clinicalgenome.org/r/44222ace-cc4c-46a2-9ff7-a1a6d310a317","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012464.5(TLL1):c.1885A>G (p.Ile629Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116645"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/580aa6d2-e59a-4495-ae1b-faa38362fea0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/580aa6d2-e59a-4495-ae1b-faa38362fea0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30293987","allele":{"id":"https://genegraph.clinicalgenome.org/r/124cfe6f-6b20-4026-b895-1e8a238e6b9e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012464.5(TLL1):c.2578A>G (p.Thr860Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358695524"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4b2ba946-aafc-4b1c-b225-deac71eae59f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b2ba946-aafc-4b1c-b225-deac71eae59f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data in Sieron et al. 2019 (PMID: 30538173) but experts chose not to score due to the same functional study providing evidence for a functional effect in a common variant","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/4b2ba946-aafc-4b1c-b225-deac71eae59f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18830233","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b6ea14b-56e3-4868-96b2-c8e27e681225","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_012464.5(TLL1):c.544A>C (p.Met182Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116643"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.3},{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f33fa57a-b24f-4eb5-a0f5-20d28e8172e3","type":"EvidenceLine","dc:description":"Downgraded because the phenotype is only obvious in homozygous mutants for a dominant disease gene. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e586c1c-db37-41d0-94bd-c5d35dfc7853","type":"Finding","dc:description":"Homozygous mutants were embryonic lethal (died between 14.5 and 16.5 dpc), with death at mid-gestation from cardiac failure and a unique constellation of developmental defects that were apparently confined solely to the heart.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10331975","rdfs:label":"Clark Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/37ed8aea-d2e0-4bab-9e21-4f5ac823ce99_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5d67b10-9410-4447-84cb-ea509a95bb83","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6c98d0f-8be6-47cd-9a7b-d8cdbdb01891","type":"Finding","dc:description":"Nkx2-5, which is definitive by ClinGen for NKX2-5 related congenital, conduction and myopathic heart disease, increased Tll-1 expression.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19366374","rdfs:label":"Sabirzhanova Luciferase Assay ","demonstrates":{"id":"obo:MI_0935"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c3e14ec5-87f5-49c8-b60b-9d991e91070b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8cdf9f1-9872-4b24-a2f8-4c5245dae411","type":"Finding","dc:description":"real-time PCR analysis showed that tll1 was expressed significantly lower within the posterior secondary heart field in Tbx5 knockdown mice","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26744331","rdfs:label":"Zhang Protein Interaction","demonstrates":{"id":"obo:MI_0935"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/df78c78a-16af-4333-95a2-31a1163c9a6e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b82937f-5970-4cf4-b9ca-c34f16406408","type":"Finding","dc:description":"In situ hybridization was performed analyzing the expression of Tll1 in normal developing mouse hearts. Consistent with roles in cardiac development, Tll1 expression was specific to precardiac tissue and endocardium in 7.5 and 8.5 days p.c. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10331975","rdfs:label":"Clark In situ hybridization","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Limited","sequence":8509,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/cscNeKVojVk","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:11843","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_37ed8aea-d2e0-4bab-9e21-4f5ac823ce99-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}